RxVantage
PrivateLast Round
Growth Equity
Jan 19, 2022
Total Funding Raised
$4.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RxVantage operates in Healthcare & Life Sciences and is based in El Segundo, California. Its latest recorded funding round was a Growth Equity round in January 2022.
RxVantage is a healthcare technology company that provides a digital platform connecting healthcare providers with educational resources and experts from life science companies.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Sales Enablement, Workflow Automation
Business Model
B2B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxVantage Comparables
Compare RxVantage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Veeva Systems | 73% | |
| symplr | 67% | |
| Within3 | 64% |
For institutional investors. Book with your work email.
RxVantage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 19, 2022 | ||||
| Series A | Dec 31, 2011 | ||||
| Seed | Jun 1, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RxVantage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dRx Capital | Growth Equity |
| McKesson Ventures | Growth Equity |
| Spectrum Equity | Growth Equity |
| Javelin Venture Partners | Growth Equity, Series A |
| Slater Technology Fund | Series A, Growth Equity, Seed |
| Wavemaker Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 137% MoM, reaching 92.6K.
- Jul 20, 2026
Open roles increased to 414, 230% of headcount.
For institutional investors. Book with your work email.
RxVantage Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RxVantage's valuation, stock price, and market status.
Is RxVantage a public or private company?
RxVantage is a private company.
What is the current stock price of RxVantage?
RxVantage is a private company, so its shares have no public market price. Caplight tracks RxVantage's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RxVantage worth (valuation)?
Valuation information for RxVantage is not publicly available.
Can I buy RxVantage stock?
RxVantage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RxVantage's last funding round?
RxVantage's most recent funding round was Growth Equity on January 19, 2022.
Who are the main investors in RxVantage?
Key investors in RxVantage include McKesson Ventures, Spectrum Equity, Javelin Venture Partners, Slater Technology Fund.
Will RxVantage IPO soon?
No public IPO plans have been announced for RxVantage.
How can I track RxVantage secondary market activity?
Caplight tracks bids, offers, and trades in RxVantage's shares on secondary markets.